2018 PPMI Annual Meeting Summary

The 2018 PPMI Annual Investigator’s Meeting took place on May 2-3 in New York City.  There were more than 200 attendees present, including PPMI investigators and coordinators, Industry Scientific Advisory Board representatives, The Edmond J. Safra Fellowship in Movement Disorders fellows and fellowship directors, the PPMI Patient Committee, and the PPMI Steering Committee. This meeting provides the opportunity for various study stakeholders to share operational and scientific updates and to discuss the future of the initiative.  The annual meeting remains a critical component of the study, providing the space for collaboration, innovation, and planning.

The full meeting agenda is available here.  Please see below for links to the meeting presentations:

PPMI Enrollment and Compliance Update

PPMI Deliverables

PPMI Data Blitz

PPMI Biorepository Update

PPMI Biospecimen Analyses

RNA-Seq in PPMI Whole-Blood Samples

PPMI Beyond 2018


Wearables and Digital Sensor Technology

Digital Tools to Measure Parkinson’s disease

Moving earlier in the neurodegenerative disease continuum. Analogies between Alzheimer’s and Parkinson’s diseases

2018 PPMI Site Awards

Day 1 Closing Remarks

Participation in Clinical Trials

Phenoconversion in PPMI

PPMI Pathology Core Update

Systematic investigation of nominated candidate markers in CSF (and serum) for PD

Navigating the PPMI Database

PPMI Epigenetics

Enrollment of LRRK2 and GBA Genetic Cohort

Gait Sub-Study

DAT Imaging in a cohort of p.A53T SNCA PD patients versus typical PD

PPMI Genetics

PPMI Informatics Core

Critical Path for Parkinson’s Consortium, Accelerating therapies for PD

Data Sharing / Standardization

PPMI in the Medical Literature

PPMI Goals 2019